Foundry Partners, LLC Charles River Laboratories International, Inc. Transaction History

Foundry Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Apr 22, 2019	SELL	$104.82 - $146.73 $4.81 Million - $6.73 Million	-45,863 Closed	0 $0
Q3 2018 Oct 17, 2018	BUY	$112.11 - $134.54 $8,184 - $9,821	73 Added 0.16%	45,863 $6.17 Million
Q2 2018 Jul 19, 2018	SELL	$102.37 - $117.25 $2.44 Million - $2.8 Million	-23,850 Reduced 34.25%	45,790 $5.14 Million
Q1 2018 May 16, 2018	SELL	$98.19 - $115.2 $1.98 Million - $2.33 Million	-20,209 Reduced 22.49%	69,640 $7.43 Million
Q4 2017 Jan 25, 2018	SELL	$100.43 - $118.09 $93,399 - $109,823	-930 Reduced 1.02%	89,849 $9.83 Million
Q3 2017 Oct 31, 2017	BUY	$96.72 - $109.26 $8.78 Million - $9.92 Million	90,779	90,779 $9.81 Million

691

51.6M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $8.38B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Foundry Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Foundry Partners, LLC with notifications on news.